TrialEuropean journal of clinical pharmacology2016

Single therapeutic and supratherapeutic doses of sacubitril/valsartan (LCZ696) do not affect cardiac repolarization.

Thomas H Langenickel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.